By Kevin E. Noonan — In Becton, Dickinson & Co. v. Baxter Corp. Englewood, the Federal Circuit overturned a decision by the Patent Trial and Appeal Board (PTAB) in an inter partes review that claims in the challenged patent were not invalid for obviousness. The patent at issue, U.S. Patent No. 8,554,579, is directed to telemedicine methods and particularly to methods for preparing patient-specific doses of pharmaceuticals. Claim 8 was considered representative by the Court: 8. A system for preparing and managing patient-specific dose orders that have been entered into a first system, comprising: . . . a dose preparation…
